Genetics of Ultrasonographic Carotid Atherosclerosis

Arteriosclerosis, Thrombosis, and Vascular Biology - Tập 24 Số 9 - Trang 1567-1577 - 2004
Teri A. Manolio1,2,3,4, Eric Boerwinkle1,2,3,4, Christopher J. O’Donnell1,2,3,4, Alexander F. Wilson1,2,3,4
1From the Division of Epidemiology and Clinical Applications (T.A.M., C.J.O.), National Heart, Lung, and Blood Institute, Bethesda, Md; the Human Genetics Center (E.B.), University of Texas Health Science Center at Houston, Houston, Tex; the National Heart, Lung, and Blood Institute Framingham Heart Study (C.J.O.), Framingham, Mass; and the Inherited Disease Research Branch (A.F.W.), National Human Genome Research Institute, Baltimore, Md.
2the Human Genetics Center (E.B.), University of Texas Health Science Center at Houston, Houston, Tex
3the Inherited Disease Research Branch (A.F.W.), National Human Genome Research Institute, Baltimore, Md.
4the National Heart, Lung, and Blood Institute Framingham Heart Study (C.J.O.), Framingham, Mass

Tóm tắt

The search for genes related to the cause of common complex disorders such as cardiovascular disease has been frustrating, partly because of the many factors known to contribute to cardiovascular disease and the potential “distance” of cardiovascular disease as a phenotype from genes and gene products. Linkage and association studies for phenotypes more proximal in the pathway from DNA sequence variation to overt clinical disease, such as ultrasound-defined carotid atherosclerosis, may potentially be more enlightening. Only one genetic variant previously reported to be associated with atherosclerosis or clinically evident cardiovascular disease, matrix metalloproteinase (MMP) 3, has shown consistently positive associations with carotid disease, although it has not been studied widely. Another, PON1 L55M, is weakly associated in subgroups only, and 2, ApoE and MTHFR, are equivocal. Genetic variants reported to be associated with clinical cardiovascular disease show weak or no relationship to carotid atherosclerosis. This may reflect the known inconsistency in associations of genetic variants with clinical cardiovascular disease itself. Alternatively, genetic determinants of ultrasound-defined carotid atherosclerosis may differ from those of clinically manifest cardiovascular disease and may require pursuit through large-scale genomic studies of carotid atherosclerosis as a distinct phenotype.

Từ khóa


Tài liệu tham khảo

10.1056/NEJM198411013111802

10.1161/str.28.6.1158

10.1056/NEJM199901073400103

10.1161/circ.96.5.1432

10.7326/0003-4819-128-4-199802150-00002

10.1161/atv91.11.5.1911709

10.1161/str.22.9.1926258

10.1161/str.27.2.224

10.1111/j.1475-097X.1991.tb00676.x

10.1161/atv91.12.1.1731854

10.1016/S0895-4356(97)00059-0

10.1161/01.str.0000048214.56981.6f

1996, Stroke, 1927, 69

10.1161/01.ATV.6.4.378

10.1002/(SICI)1098-2272(1999)16:2<165::AID-GEPI4>3.0.CO;2-H

10.1111/j.1651-2227.2000.tb02782.x

10.1161/01.cir.0000081764.35431.de

10.1053/euhj.2001.3111

10.1056/NEJM200009213431203

10.1161/01.atv.0000051383.75507.60

10.1161/str.27.5.833

10.1161/01.atv.0000032656.91352.5e

10.1007/s004390050804

10.1161/01.atv.0000013313.70875.a7

10.1016/S0021-9150(02)00317-9

10.1161/01.str.0000019909.71547.aa

10.1161/01.atv.0000015329.15481.e8

10.1016/S0021-9150(00)00639-0

10.1016/1047-2797(96)00001-4

10.1053/ajkd.2000.17682

10.1161/str.32.6.1250

10.1016/S0021-9150(02)00423-9

1995, J Hypertens, 13, 1593

10.1016/S0895-7061(99)00193-4

10.1161/01.str.0000043827.03966.ef

10.1016/S0021-9150(98)00100-2

10.1161/01.str.0000014325.54063.1a

1995, Am J Hum Genet, 56, 1379

10.1016/0197-2456(92)90012-O

10.1161/atvb.18.3.487

10.1056/NEJMoa012673

10.1161/01.str.0000058159.63950.ea

2003, Ultrasound Med Biol, 1929, 1415

10.1161/atvb.19.2.366

2004, Stroke, 1935, 649

2002, Int Angiol, 21, 63

10.1177/000331970305400301

10.1172/JCI114844

10.1016/S0021-9150(98)00120-8

10.1016/S0021-9150(98)00009-4

10.2337/diacare.21.5.836

10.1161/hyp.32.3.579

10.1007/s001099900061

10.1161/atvb.19.8.1969

2000, J Formos Med Assoc, 99, 895

10.1046/j.1523-1755.2000.00876.x

10.1161/str.32.11.2465

10.1007/s100380170079

2000, Int Angiol, 1919, 337

10.1097/00004872-200208000-00018

10.1291/hypres.25.875

10.1093/gerona/57.9.M611

10.1161/circ.91.11.2721

10.1161/str.26.8.1329

10.1161/circ.94.4.704

10.1097/00004872-199610000-00005

1996, Coron Artery Dis, 7, 51

10.2337/diab.46.4.682

10.1161/hyp.30.3.569

10.1046/j.1365-2362.1999.00476.x

1999, J Nephrol, 12, 261

10.1016/S0895-7061(99)00186-7

10.1093/ndt/17.12.2184

10.1016/0002-9149(93)90732-R

10.1093/aje/155.6.487

10.1161/atvb.17.1.91

10.1016/S0021-9150(00)00570-0

10.1161/str.27.10.1755

10.1093/ndt/12.4.691

10.1002/(SICI)1096-9136(199709)14:9<748::AID-DIA469>3.0.CO;2-N

10.1016/S0021-9150(00)00383-X

10.1161/str.32.9.1947

10.1046/j.1365-2796.2002.01011.x

10.1161/01.str.0000062901.54157.12

10.1097/00004872-200018040-00012

10.1161/str.28.5.951

2000, Int Angiol, 1919, 331

10.1097/00004872-200212000-00015

2003, Am J Kidney Dis, 1941, 822

10.1016/S0021-9150(99)00082-9

10.1053/euhj.1999.1738

10.1016/S0021-9150(01)00499-3

10.1161/res.68.2.1991349

10.1161/circ.95.6.1532

10.1161/atvb.16.1.97

1997, Endocrinol Rev, 18, 662

10.1161/hyp.38.1.110

1995, J Hum Hypertens, 9, 681

10.1016/S0895-7061(99)00006-0

2001, Clin Genet, 59, 316, 10.1034/j.1399-0004.2001.590504.x

10.1042/CS20030156

10.1161/hyp.28.6.1076

10.1161/str.30.10.2180

10.1161/str.30.5.969

10.1161/circ.93.1.7

1998, Arterioscler Thromb Vasc Biol, 1918, 1838

10.1046/j.1365-2362.1998.00281.x

10.1161/circ.99.18.2383

2000, Metabolism, 1949, 718

2000, Stroke, 31, 990

2002, Eur J Clin Invest, 1932, 24

10.2337/diab.46.12.2102

10.1159/000045922

10.1016/S0021-9150(00)00696-1

2001, Am J Hypertens, 1914, 371

10.1161/01.str.0000075769.09092.82

10.1161/str.29.10.2043

10.1055/s-2001-14836

10.1016/S0021-9150(98)00031-8

10.1097/00019501-199912000-00008

10.1161/atvb.20.11.2441

10.1016/S0021-9150(99)00324-X

2003, Arterioscler Thromb Vasc Biol, 1923, 1465

10.2169/internalmedicine.37.581

10.1016/S0021-9150(02)00070-9

10.1053/meta.2001.25641

10.1161/str.32.3.735

10.1046/j.1365-2796.2002.00933.x

10.1161/str.29.9.1908

2002, Clin Chem, 48, 989, 10.1093/clinchem/48.7.989

10.1016/S0021-9150(01)00466-X

10.1016/S0049-3848(98)00019-X

10.1161/circ.98.25.2815

2004, Stroke, 1935, e65

10.1161/01.cir.0000055189.18831.b1

10.1161/atvb.20.6.1600

10.1161/atvb.20.12.2657

10.1161/01.str.0000031929.05665.da

10.1161/01.str.0000015558.63492.b6

10.1016/S0195-668X(03)00313-0

10.1161/01.str.0000053849.09308.b2

10.1016/S0021-9150(01)00468-3

2000, J Clin Endocrinol Metab, 85, 2266

1997, J Hypertens, 19, 1579

10.1016/S0140-6736(00)82009-7

2000, Arterioscler Thromb Vasc Biol, 1920, 484

10.1161/str.30.4.841

10.1046/j.1365-2362.2003.01108.x

10.1161/atv91.12.1.1731860

10.1161/atvb.16.8.984

10.1046/j.1365-2362.1998.00399.x

10.1046/j.1365-2362.2001.00915.x

10.1034/j.1399-0004.2002.610603.x

10.1007/s004390050258

10.1046/j.1365-2362.1997.1820730.x

10.1161/01.str.0000069160.05292.41

10.1161/atv91.14.6.8199177

10.1161/circ.103.15.1949

10.1161/str.23.9.1355620

10.1161/atv91.13.11.8218095

10.1016/0021-9150(88)90106-2

10.1016/0021-9150(91)90008-Q

10.1046/j.1365-2362.2000.00595.x

2001, J Lipid Res, 1942, 1717

10.1086/381559

10.1016/S0049-3848(97)00295-8

10.2337/diabetes.51.5.1523

2000, J Investig Med, 48, 198

10.1161/01.str.0000055941.61801.5a

10.1161/01.str.0000057815.79289.ec

10.1056/NEJMoa025079

10.1016/S0021-9150(01)00420-8

10.2337/diacare.26.2.458

10.1016/S0021-9150(03)00091-1

10.1046/j.1365-2796.1999.00564.x

10.1161/str.31.12.3015

10.1161/hyp.38.5.1185

10.1016/S0021-9150(00)00569-4

10.1016/S0006-291X(02)00137-7

10.1046/j.1365-2796.2003.01263.x